-
Mashup Score: 6The HIV Field Needs Early-Stage Investigators (VIDEO) - 3 day(s) ago
The HIV research community is led by scientists with deep personal commitments to improving the lives of people with and affected by HIV. Our collective decades of work have generated HIV testing, prevention and treatment options beyond what we could have imagined in the 1980s. Those advances enable NIAID to explore new frontiers: expanding HIV prevention and treatment modalities, increasing understanding of the interplay between HIV and other infectious and non-communicable diseases, optimizing choice and convenience, and building on the ever-growing knowledge base that we need to develop a preventive vaccine and cure. The next generation of leaders will bring these concepts to fruition, and we need to welcome and support them into the complex and competitive field of HIV science.
Source: www.niaid.nih.govCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13Children disproportionately wearing the scars of the war in Gaza - Geneva Palais briefing note - 5 day(s) ago
This is a summary of what was said by UNICEF Communication Specialist Tess Ingram – to whom quoted text may be attributed – at today’s press briefing at the Palais des Nations in Geneva
Source: www.unicef.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 30Record Numbers in the US Are Homeless. Can Cities Fine Them for Sleeping in Parks and on Sidewalks? - 6 day(s) ago
The most significant case in decades on homelessness has reached the Supreme Court as record numbers of people in America are without a permanent place to live
Source: www.usnews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 6PEPFAR Reauthorization by Congress Urgent for Global Health - 9 day(s) ago
This Viewpoint discusses the importance of the US Congress reauthorizing funding for the President’s Emergency Plan for AIDS Relief, a program developed in 2003 that has played a critical role in fighting HIV/AIDS worldwide as well as other emerging infections and noncommunicable diseases.
Source: jamanetwork.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 17
U.S. National Institutes of Health guidelines currently recommend nirmatrelvir/ritonavir (Paxlovid) as first-line therapy for outpatients with COVID-19
Source: www.jwatch.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 28Sexually Transmitted Infections—A Closer Look at NIAID Research - 10 day(s) ago
Sexually transmitted infections (STIs) are caused by bacteria, viruses, or parasites. NIAID supports research across the spectrum from basic to clinical science to develop effective diagnostic, preventive and therapeutic approaches to STIs in alignment with the National STI Strategic Plan. In recognition of National STI Awareness Week, NIAID shares a snapshot of new projects and recent scientific advances in STI research.
Source: www.niaid.nih.govCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7Case Series Examining the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial - CROI Conference - 10 day(s) ago
Background: Long-acting antiretroviral therapy (LA-ART) is novel and has been used for both virologically-suppressed (VS) and viremic patients with adherence challenges. The currently-approved LA-ART combination – cabotegravir (CAB) and rilpivirine (RPV) – is limited by the relatively high prevalence (up to 10%) of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistant virus globally and is not endorsed
Source: www.croiconference.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 17
Samantha Power becomes first US official to confirm famine, while aid workers decry continuing lack of help
Source: www.theguardian.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 10
Despite the use of vaccines, seasonal influenza remains a risk to public health. We previously proposed the inactivated whole virus particle vaccine (WPV) as an alternative to the widely used split vaccine (SV) for the control of seasonal and pandemic influenza based on the superior priming potency of WPV to that of SV. In this study, we further examined and compared the immunological potency of monovalent WPV and SV of A/California/7/2009 (X-179A) (H1N1) pdm09 (CA/09) to generate immune responses against heterologous viruses, A/Singapore/GP1908/2015 (IVR-180) (H1N1) pdm09 (SG/15), and A/duck/Hokkaido/Vac-3/2007 (H5N1) (DH/07) in mice. Following challenge with a lethal dose of heterologous SG/15, lower virus titer in the lungs and milder weight loss were observed in WPV-vaccinated mice than in SV-vaccinated ones. To investigate the factors responsible for the differences in the protective effect against SG/15, the sera of vaccinated mice were analyzed by hemagglutination-inhibition (HI
Source: www.mdpi.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9
Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.
Source: www.reuters.comCategories: General Medicine News, Partners & KOLsTweet
HIV: Need to support early-stage investigators to enter this important field. Topic very close to my heart. One way is to make it easier for young investigators to get grants (e.g. increase payline at NIH) https://t.co/o53SUfLm1h